Sharps Compliance Corp. Added to Russell Microcap(r) Index
* Reuters is not responsible for the content in this press release.
HOUSTON, June 29, 2009 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq:SMED)
("Sharps" or the "Company"), a leading provider of cost-effective disposal
solutions for medical and pharmaceutical waste generated outside the hospital
setting, today announced that it has been added to the Russell Microcap(r)
Index, effective after the close of trading on Friday, June 26, 2009.
Sharps Compliance has recently announced several significant events and
milestones, including the launching of its Sharps(r)MWMS(tm), a Medical Waste
Management System, the signing of a $40 million contract with an agency of the
U.S. Government; its graduation from the OTC Bulletin Board to the NASDAQ, and
its solution for the problem of how to dispose of unused prescription
medications by launching RxTakeAway(tm) -- an innovative and
environmentally-conscious disposal solution designed to protect children and
teenagers as well as the environment.
Key drivers for the Company's long-term growth are strengthening legislation
mandating the proper disposal of medical waste such as hypodermic needles,
lancets and any other medical device or objects used to puncture or lacerate the
skin (referred to as "sharps") as well as unused medications, the rising
awareness of the need to properly handle sharps medical waste and unused
prescriptions for safety and environmental concerns, the significant increase in
self-injectable medications and Sharps' leadership position in the development
and sale of products designed to properly, conveniently, and cost effectively
dispose of medical and pharmaceutical waste through the U.S. Postal Service.
About the Russell Microcap(r) Index
The Russell Microcap(r) Index measures the stock performance of the microcap
segment of the U.S. equity market, which includes the smallest 1,000 companies
in the small-cap Russell 2000(r) index and the next 1,000 smallest U.S.
securities based on market capitalization. Russell indexes are widely used by
investment managers and institutional investors for index funds and as
benchmarks for both passive and active investment strategies. Russell determines
index membership by objective, market capitalization rankings and all Russell
indexes are reconstituted annually in June to ensure that they are truly
representative of global equity markets.
About Sharps Compliance Corp.
Headquartered in Houston, Texas, Sharps Compliance is a leading provider of
cost-effective disposal solutions for medical and pharmaceutical waste generated
outside the hospital setting. The Company's flagship product, the Sharps
Disposal by Mail System(r), is a cost-effective and easy-to-use solution to
dispose of medical waste such as hypodermic needles, lancets and any other
medical device or objects used to puncture or lacerate the skin (referred to as
"sharps").
The Sharps(r)MWMS(tm), a Medical Waste Management System, is a comprehensive
medical waste solution which includes an array of services and products
necessary to effectively collect, store and dispose of medical waste outside of
the hospital setting. The System, which is designed for rapid deployment,
features the Sharps Disposal By Mail System(r) products combined with
warehousing, inventory management, training, data and other services necessary
to provide a comprehensive solution. The Sharps(r)MWMS(tm) is designed to be an
integral part of governmental and commercial emergency preparedness programs.
The Company also offers a number of products specifically designed for the home
healthcare market and products for the safe disposal of unused pharmaceuticals,
RxTakeAway(tm). Sharps Compliance focuses on targeted growth markets such as the
pharmaceutical, retail, commercial, and hospitality markets, as well as serving
a variety of additional markets. Sharps is a leading proponent and participant
in the development of public awareness and solutions for the safe disposal of
needles, syringes and other sharps as well as unused pharmaceuticals in the
community setting.
As a fully integrated manufacturer providing customer solutions and services,
Sharps Compliance's solid business model, with strong margins and significant
operating leverage, and early penetration into emerging markets, uniquely
positions the company for strong future growth.
More information on Sharps Compliance can be found on its website at:
www.sharpsinc.com
Safe Harbor Statement
The information made available in this press release contains certain
forward-looking statements which reflect Sharps Compliance Corp.'s current view
of future events and financial performance. Wherever used, the words "estimate",
"expect", "plan", "anticipate", "believe", "may" and similar expressions
identify forward-looking statements. Any such forward-looking statements are
subject to risks and uncertainties and the company's future results of
operations could differ materially from historical results or current
expectations. Some of these risks include, without limitation, the company's
ability to educate its customers, development of public awareness programs to
educate the identified consumer, customer preferences, the Company's ability to
scale the business and manage its growth, the degree of success the Company has
at gaining more large customer contracts, managing regulatory compliance and/or
other factors that may be described in the company's annual report on Form 10-K,
quarterly reports on Form 10-Q and/or other filings with the Securities and
Exchange Commission. Future economic and industry trends that could potentially
impact revenues and profitability are difficult to predict. The company assumes
no obligation to publicly update or revise its forward-looking statements even
if experience or future changes make it clear that any projected results express
or implied therein will not be realized.
-0-
CONTACT: Sharps Compliance Corp.
David P. Tusa, Executive Vice President, Chief Financial
Officer & Business Development
(713) 660-3514
dtusa@sharpsinc.com
Kei Advisors LLC
Investor Relations
Deborah Pawlowski
(716) 843-3908
dpawlowski@keiadvisors.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters